Table: Pharmarise Holdings - 6-MTH group results
Jan 14 (Reuters)-
Pharmarise Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2020 Nov 30, 2019 May 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 25.67 25.76 51.93
(-0.4 pct) (+0.4 pct) (+1.8 pct)
Operating 525 mln 521 mln 1.19
(+0.8 pct) (+198.4 pct) (+14.8 pct)
Recurring 536 mln 522 mln 1.17
(+2.7 pct) (+324.0 pct) (+14.6 pct)
Net 127 mln 595 mln 378 mln
(-78.6 pct) (-34.5 pct)
EPS 13.73 yen 62.41 yen 40.62 yen
EPS Diluted 11.87 yen 53.84 yen
Ann Div 14.00 yen 14.00 yen
-Q2 div NIL NIL
-Q4 div 14.00 yen 14.00 yen
NOTE - Pharmarise Holdings Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T